Research workbench
Crystal structure of the transcriptional regulator ethr in a ligand bound conformation opens therapeutic perspectives against tuberculosis and leprosy
Analyse Crystal structure of the transcriptional regulator ethr in a ligand bound… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 1U9N
- Type
- protein
- Length
- 194 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Transcriptional repressor ethr
- UniProt
- P96222
- Ligands
- CNS
- Pockets
- 1 · best druggability 0.75
Structure
x-ray diffraction · 1 distinct chain · 75% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Transcriptional repressor ethr | protein | 194 | 75% helix, 0% strand | P96222 |
Ligands and binding sites
- CNS · Hexadecyl octanoate · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 286 | 0.75 | 0.87 | 39 | CNS |
Modifications
Observed in the structure: 4 modified (engineered).
Compared structures
- 1U9N · Crystal structure of the transcriptional regulator EthR in a ligand bound conformation… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P96222
- Elsewhere: RCSB PDB 1U9N · PDBe 1U9N · UniProt P96222
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.